ArticleFrontiers in public health2024

Modification of gemcitabine with oxaliplatin in China for unresectable gallbladder cancer: a cost-effectiveness analysis.

Zhaoyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.